PYRIMIIDINVERBINDUNGEN
Patent europeic · EP1597251 · Stritgà
Inscripziun en il register
- Numer da publicaziun
- EP1597251
- Numer da la dumonda
- EP04710264
- Gener
- Patent europeic cun effect per la Svizra ed il Liechtenstein
- Status
- Stritgà
- Scrittira da patent
- Concedì
- Annunzià
- 11-02-2004
- Publitgà
- 23-11-2005
- Concedì
- 10-06-2009
- Stritgà
- 28-02-2010
- Motiv
- Taxa annuala betg pajada
- Classas IPC
- C07D 403/12 (2006.01)C07D 239/48 (2006.01)C07D 405/12 (2006.01)A61K 31/505 (2006.01)A61K 31/506 (2006.01)A61P 35/00 (2006.01)
- Prioritad
- US 448795 P 20.02.2003
- Dumonda PCT
- PCT/US2004/004197 11.02.2004
- Publicaziun PCT
- WO2004/074244 02.09.2004
- Lingua da l’annunzia
- englais
- Funtauna
- Swissreg
Istorgia
Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.
- 22-09-2010
Stritgà, taxa betg pajada
Published in Swissreg on 22.09.2010
- 10-06-2009
Concedì
Published in Swissreg on 10.06.2009
Partidas
Inventur
DAVIS-WARD, Ronda, GlaxoSmithKline
Research Triangle Park, NC 27709, US
MOOK, Robert Anthony Jr., GlaxoSmithKline
Research Triangle Park, NC 27709, US
NEEB, Michael J., GlaxoSmithKline
King of Prussia, PA, US
SALOVICH, James M., GlaxoSmithKline
Research Triangle Park, NC 27709, US
Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.